Department of Nephrology, Division of Medicine, Royal Darwin Hospital, Darwin, Northern Territory, Australia; Royal Darwin Hospital Campus, Flinders University and Northern Territory Clinical School, Darwin, Northern Territory, Australia.
Intern Med J. 2013 Oct;43(10):1059-66. doi: 10.1111/imj.12274.
Chronic kidney disease causes high morbidity and mortality among Indigenous Australians of the Northern Territory (NT). Studies have shown chronic kidney disease rates of 4-10 times higher in indigenous than non-indigenous Australians and prevalent dialysis rates of 700-1200 per million population. For most patients with end-stage renal failure, renal transplantation provides the optimal treatment for people with end-stage renal disease. It reduces morbidity and mortality, and improves survival and quality of life. Graft and patient survival rates of over 80% at 5 years depending on the donor source (deceased vs living donor) are expected worldwide. However, this is not the case in Indigenous Australians of the NT where graft and patient survival are both around 50% at 5 years suggesting death with functioning graft as the most common cause of graft loss. It would provide the best treatment option for indigenous people most of who live in remote (18%) and very remote communities (63%). Many have to relocate from their communities to urban or regional centres for dialysis. Available options to avoid relocation include peritoneal dialysis, home haemodialysis and community health centre dialysis, but the acceptance rates for these are low, hence renal transplantation would provide the best option. There is evidence of identified barriers to renal transplantation for indigenous people of the NT. This review explores published data on why rates of renal transplantation in indigenous people of the NT are low and the reasons for poor outcomes highlighting possible areas of improvement.
慢性肾脏病导致北领地(NT)的澳大利亚原住民发病率和死亡率很高。研究表明,与非原住民相比,原住民的慢性肾脏病发病率高出 4-10 倍,普遍的透析率为每百万人口 700-1200 人。对于大多数终末期肾衰竭患者,肾移植为终末期肾病患者提供了最佳治疗方法。它降低了发病率和死亡率,并提高了生存率和生活质量。在全球范围内,根据供体来源(已故供体与活体供体)的不同,预计 5 年内移植物和患者的存活率超过 80%。然而,在北领地的澳大利亚原住民中,5 年内移植物和患者的存活率均约为 50%,这表明功能移植物的死亡是移植物丢失的最常见原因。对于大多数生活在偏远地区(18%)和非常偏远地区(63%)的土著人民来说,这将提供最佳的治疗选择。许多人必须从社区搬迁到城市或地区中心进行透析。为避免搬迁,可以选择腹膜透析、家庭血液透析和社区卫生中心透析,但这些方法的接受率较低,因此肾移植是最佳选择。有证据表明,北领地的土著人民在进行肾移植方面存在障碍。本综述探讨了北领地原住民肾移植率较低的原因以及预后不良的原因,重点强调了可能需要改进的领域。